141
Views
0
CrossRef citations to date
0
Altmetric
Psychotherapeutics Column

Classic Monoamine Oxidase Inhibitors for Depression: Update on Nursing Care

, LL.MORCID Icon, , MA (Oxon.), , RN & , MD
 

Authors’ contributions

VVdE and LG contributed equally.

Disclosure statement

VVdE is an external research consultant for, and receives or has received consulting fees from: PsychoTropical Research, NeuraWell Therapeutics, Aristo Pharma GmbH; he has stock options in NeuraWell Therapeutics. LG has nothing to report. ST has received fees from NeuraWell Therapeutics for research unrelated to the present manuscript. PKG has equity interests in, and is on the advisory board of NeuraWell Therapeutics, the company that has the patent for a modified form of tranylcypromine.

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.